Trends in invasive pneumococcal disease among older adults in Olmsted County, Minnesota

Journal of Infection

Volumn 59, Issue 3, 2009, Pages 188-193

  Tsigrelis, Constantine ^a   Tleyjeh, Imad M ^a,b   Lahr, Brian D ^c   Nyre, Lisa M ^a   Virk, Abinash ^a   Baddour, Larry M ^a  

^a Mayo Clinic   (United States)

^b KING FAHAD MEDICAL CITY   (Saudi Arabia)

^c MAYO CLINIC   (United States)

Author keywords

Aged; Cohort studies; Incidence; Pneumococcal infections; Streptococcus pneumoniae

Indexed keywords

ADULT; AGED; AGING; ARTICLE; FEMALE; HEALTH SURVEY; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PNEUMOCOCCAL INFECTION; POPULATION RESEARCH; STREPTOCOCCUS PNEUMONIAE; TREND STUDY; UNITED STATES;

AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MINNESOTA; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, PNEUMOCOCCAL; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 69749092181     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2009.07.004     Document Type: Article

References (17)

1. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al., For the active bacterial core surveillance of the emerging infections program network. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348 (2003) 1737-1746
2. Singleton R.J., Hennessy T.W., Bulkow L.R., Hammitt L.L., Zulz T., Hurlburt D.A., et al. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297 (2007) 1784-1792
3. Albrich W.C., Baughman W., Schmotzer B., and Farley M.M. Changing characteristics of invasive pneumococcal disease in metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine. Clin Infect Dis 44 (2007) 1569-1576
4. Lexau C.A., Lynfield R., Danila R., Pilishvili T., Facklam R., Farley M.M., et al., for the active bacterial core surveillance team. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 294 (2005) 2043-2051
5. Hicks L.A., Harrison L.H., Flannery B., Hadler J.L., Schaffner W., Craig A.S., et al., for the active bacterial core surveillance program of the emerging infections program network. Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (pcv7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 196 (2007) 1346-1354
6. Musher D.M. Pneumococcal vaccine-direct and indirect ("herd") effects. N Engl J Med 354 (2006) 1522-1524
7. Hammitt L.L., Bruden D.L., Butler J.C., Baggett H.C., Hurlburt D.A., Reasonover A., et al. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J Infect Dis 193 (2006) 1487-1494
8. Melton III L.J. History of the Rochester epidemiology Project. Mayo Clin Proc 71 (1996) 266-274
9. Tleyjeh I.M., Steckelberg J.M., Murad H.S., Anavekar N.S., Ghomrawi H.M., Mirzoyev Z., et al. Temporal trends in infective endocarditis: a population-based study in Olmsted County, Minnesota. JAMA 293 (2005) 3022-3028
10. Uslan D.Z., Crane S.J., Steckelberg J.M., Cockerill III F.R., St Sauver J.L., Wilson W.R., et al. Age- and sex-associated trends in bloodstream infection: a population-based study in Olmsted County, Minnesota. Arch Intern Med 167 (2007) 834-839
11. McNamara D.R., Tleyjeh I.M., Berbari E.F., Lahr B.D., Martinez J.W., Mirzoyev S.A., et al. Incidence of lower-extremity cellulitis: a population-based study in Olmsted County, Minnesota. Mayo Clin Proc 82 (2007) 817-821
12. Influenza & Pneumococcal Vaccination Rates for Adults 65+. http://www.health.state.mn.us/divs/idepc/diseases/flu/flupneumo.html [accessed 05.10.09]
13. Estimated vaccination coverage with individual vaccines and selected vaccination series among children 19-35 months of age by state and local area US, National Immunization Survey, Q1/2002-Q4/2007. http://www.cdc.gov/vaccines/stats-surv/imz-coverage.htm#nis [accessed 05.10.09]
14. Fleiss J.L. Statistical methods for rates and proportions. 1st ed. (1973), John Wiley & Sons, Inc, New York, NY p. 48-9
15. Centers for Disease Control and Prevention (CDC). Recommended adult immunization schedule-United States, October 2007-September 2008. MMWR Morb Mortal Wkly Rep 56 (2007) Q1-Q4
16. Lacapa R., Bliss S.J., Larzelere-Hinton F., Eagle K.J., McGinty D.J., Parkinson A.J., et al. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine. Clin Infect Dis 47 (2008) 476-484
17. Moore M.R., and Whitney C.G. Emergence of nonvaccine serotypes following introduction of pneumococcal conjugate vaccine: cause and effect?. Clin Infect Dis 46 (2008) 183-185